Phys Clinical Cases · rheumatological
Drug Induced Rheumatological Disease AND Biologics Safety — DCE Clinical Case
DCE long-case and short-case station for Drug Induced Rheumatological Disease AND Biologics Safety.
On this page
Study tools
Target exams
Drug Induced Rheumatological Disease AND Biologics Safety — Clinical Case
DCE Long Case
Patient brief
Patient: A middle-aged or older adult with multimorbidity and a presentation centred on Drug Induced Rheumatological Disease AND Biologics Safety. [1]
Presenting complaint: Subacute or acute symptoms referable to Drug Induced Rheumatological Disease AND Biologics Safety, with enough detail to force prioritisation. [1] [2]
Past history: Common cardiometabolic and organ comorbidities that interact with the plan. [2]
Medications: A polypharmacy list that includes at least one interaction or dosing issue. [2]
Examination: Key positives and critical negatives for dangerous differentials. [1]
Investigations: A small set of results that change management. [1] [2]
Tasks
- Present a prioritised problem list. [1]
- Defend investigations and immediate therapy. [1] [2]
- Provide safety-net and follow-up advice. [2]
Model discussion points
- Working diagnosis and acuity. [1]
- Differentials and discriminators. [2]
- Treatment sequence and monitoring. [1] [2] [3]
- Multimorbidity and communication. [2]
References3ShowHide
- [1]Borchers AT, Keen CL, Gershwin ME Drug-induced lupus Ann N Y Acad Sci, 2007.PMID 17893983
- [2]Johnson DB, Balko JM, Compton ML, et al. Fulminant Myocarditis with Combination Immune Checkpoint Blockade N Engl J Med, 2016.PMID 27806233
- [3]D'Gama JD, Bermas BL Safety of biologic agents for the management of rheumatic diseases during pregnancy Curr Opin Rheumatol, 2024.PMID 38456470